IL17A and metabolic dysfunction-associated steatotic liver disease: The area under curves (AUCs) of IL-1β, IL-6, and IL-17 to discriminate obese children with or without NAFLD were 0.94 (95% CI: 0.91–0.97, P < 0.001) (Figure 2A), 0.94 (95% CI: 0.91–0.96, P < 0.001) (Figure 2B), and 0.97 (95% CI: 0.96–0.99, P < 0.001) (Figure 2C), respectively.